1. Home
  2. ITRI vs LNTH Comparison

ITRI vs LNTH Comparison

Compare ITRI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Itron Inc.

ITRI

Itron Inc.

HOLD

Current Price

$91.26

Market Cap

4.7B

Sector

Industrials

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$72.76

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRI
LNTH
Founded
1977
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.9B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
ITRI
LNTH
Price
$91.26
$72.76
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$133.88
$83.20
AVG Volume (30 Days)
1.3M
875.1K
Earning Date
05-20-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
25.48
N/A
EPS
6.50
3.41
Revenue
$2,367,194,000.00
$343,374,000.00
Revenue This Year
$4.64
N/A
Revenue Next Year
$6.74
$13.47
P/E Ratio
$14.06
$21.33
Revenue Growth
N/A
3.62
52 Week Low
$88.57
$47.27
52 Week High
$142.00
$111.29

Technical Indicators

Market Signals
Indicator
ITRI
LNTH
Relative Strength Index (RSI) 39.85 52.23
Support Level N/A $69.12
Resistance Level $101.84 $73.72
Average True Range (ATR) 4.08 2.97
MACD -0.68 0.02
Stochastic Oscillator 8.20 29.18

Price Performance

Historical Comparison
ITRI
LNTH

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: